ATLX vs TECH · rev $92.5K vs P/E 65, rev $1.22B
Atlas Lithium Corporation Common Stock (ATLX) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Atlas Lithium Corporation Common Stock (ATLX) is a other industrial metals & mining company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported ATLX revenue for 2025-12-31 was $92.5K. Net income was -$28.1M. Revenue was down 87.6% from 2024-12-31 to 2025-12-31. ATLX currently screens at market cap $69.0M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
ATLX currently screens at market cap $69.0M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the ATLX and TECH stock pages for the full models.
Not investment advice.